Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan
· Delayed Price · Currency is TWD 39.35
-1.15 (-2.84%)
Mar 9, 2026, 1:21 PM CST
Pharmosa Biopharm Revenue
Pharmosa Biopharm had revenue of 4.00M TWD in the quarter ending September 30, 2025, a decrease of -90.23%. This brings the company's revenue in the last twelve months to 136.72M, up 170.62% year-over-year. In the year 2024, Pharmosa Biopharm had annual revenue of 167.57M, down -46.72%.
Revenue (ttm)
136.72M
Revenue Growth
+170.62%
P/S Ratio
37.15
Revenue / Employee
n/a
Employees
40
Market Cap
5.08B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OBI Pharma | 49.29M |
| Panion & Bf Biotech | 2.04B |
| Locus Cell | 5.18M |
| AnnJi Pharmaceutical | 23.85M |
| CHO Pharma | 3.21M |
| UnicoCell Biomed | 30.10M |
| Sinphar Pharmaceutical | 3.35B |
| Senhwa Biosciences | 1.08M |